Home › Funds › NAN FUNG TRINITY (HK) Ltd › ABVX

NAN FUNG TRINITY (HK) Ltd position in ABVX

ABIVAX SA · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 142,083 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$14.1M, representing 1.35% of its reported portfolio and ranking #29 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed ABVX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)142.08K sh
Reported value held$14.07M
Portfolio Weight1.35%
First reportedQ3 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's ABVX position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in ABVX in Q3 2025 at 101,365 shares (US$8.6M). The position peaked in Q2 2026 at 142,083 shares, worth US$18.9M. Across 5 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 142,083 shares valued at US$14.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 101.36K $8.61M New
Q4 2025 113.36K $15.29M Add
Q1 2026 128.94K $14.36M Add
Q2 2026 142.08K $18.93M Add
Q3 2026 142.08K $14.07M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 71 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held ABVX?

NAN FUNG TRINITY (HK) Ltd has disclosed ABVX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in ABVX?

As of Q3 2026, NAN FUNG TRINITY (HK) Ltd holds 142.08K shares of ABVX (ABIVAX SA), valued at $14.07M, representing 1.35% of its reported portfolio and ranking #29.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling ABVX?

In the latest 13F filing (Q3 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in ABVX. The position peaked in Q2 2026 at 142.08K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.